Genmab Appoints Annarie Lyles as Head of Business Development
News Jan 04, 2006
Genmab A/S has announced the appointment of Annarie Lyles, Ph.D. as Head of Business Development with effect from January 1, 2006.
Dr. Lyles was previously appointed Vice President, Business Development at Genmab in June 2005.
Dr. Lyles replaces Dr. Ernst Schweizer, who has retired from his position as Head of Business Development. Dr. Schweizer remains a member of the Genmab Board of Directors.
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.